JS4-2Molecular Targeting Agents and Cardiovascular Adverse Events
Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy359.001
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV
Available in full text
October 1, 2018
Elsevier BV